DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases, with late-stage development programs including REMOXY®, POSIDUR™, ELADUR®, and TRANSDUR®-Sufentanil. DURECT’s proprietary oral, transdermal and injectable depot delivery technologies enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs

Ziyang Simaiou Technology Co., Ltd., established on 2018-08-14, Business scope includes licensed projects:Production of Class II Medical Devices;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Sales of Class I Medical Devices;Sales of Class II Medical Devices;toy manufacturing;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Information Consulting Service(Not including licensing information consulting services);Business Management Consulting;Certification Consulting;Import and export;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy.

Apidel is an early-stage, privately-funded Swiss pharmaceutical company based in Geneva. Founded in 2011 by two University of Geneva researchers and an experienced industry executive, Apidel specializes in providing proprietary drug delivery solutions which enable more effective, safer and cost effective therapeutic products, which also help patients adhere to their prescribed medical treatment. Apidel’s proprietary technologies allow effective drugs, new and established, to be formulated into new pharmaceutical products with increased therapeutic potential. This provides a platform for new indications, even for established drug molecules. Apidel develops an internal pipeline of products utilizing approved pharmaceuticals and engages with pharmaceutical partners for joint development of products in various fields. All drugs formulated using Apidel’s proprietary technologies enjoy proprietary status under Apidel’s growing portfolio of granted patents and patent applications. By applying its technology to previously approved drug molecules, Apidel expects to accelerate the development and lower the clinical and regulatory risk of its product developments. By partnering, Apidel is able to generate revenue at pre-market stage and thereby increase shareholder value by ensuring an extensive pipeline of products. Apidel’s name is derived from API (Active Pharmaceutical Ingredient) DELivery, which is their primary expertise. Indeed, Apidel’s technical experience in pharmaceutical formulation and in effective drug delivery using polymeric vehicles is unrivalled.

Guizhou Provincial People's Hospital is a private company headquartered in Guiyang, China, that provides medical services.

Guangxi Weili Ark Technology Co., Ltd., established on 2005-08-02, The scope of business includes Class II6854Infusion Assist Device,Class II6821Production of medical electronic equipment(Non-self-destructing disposable syringes unless restricted or prohibited by country,Infusion set,Blood transfusion set and blood bag)(The specific project is subject to the approval of the approval department);Sales,electronics(except engine),automation equipment;Mechanical Equipment Research,to develop,Sales;computer sales;software development,Sales;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(All certificates involving licenses to operate)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

It is a biopharmaceutical company that researches and develops advanced new type pharmaceuticals / cosmetics . Drug delivery systems that they intensively research and develop are transdermal delivery formulations Patient-friendly administration through the route of administration and formulation modification of existing oral agents It is a patch formulation. They have world-class skin permeation enhancement technology, various patch structure design technology, They supply products to domestic and overseas partners based on drug release control technology and manufacturing process technology. They have world-class skin permeation enhancement technology, various patch structure designing technology, drug release control technology and manufacturing process technology based on innovative research and development aiming first-in-class. Pharmaceutical KGMP production facility, after strict process control and quality inspection, produce medicinal products and supply products to domestic and overseas partners. ICEQUE Co., Ltd. is committed to the improvement of quality of life through the development of new drugs They are doing their best to grow into a global company.

The history of a pharmaceutical company is a significant element of its commitment, energy and solidity expressed over time in its own territory and in support of its patients. Molteni Farmaceutici represents one of the centers of excellence in European pharmaceutical production and has over time acquired its own distinctive competitive know-how in the development, production and marketing of opioid drugs .

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

Photocure ASA engages in the development and commercialization of pharmaceutical products based on photodynamic technology. Its products include Metvix for nonmelanoma skin cancer, Hexvix/Cysview for better detection and management of bladder cancer, and Cevira which is a photodynamic drug-device combination product for non-surgical treatment of high-grade cervical dysplasia. The company operates through the Commercial Franchise and Development Portfolio segments. The Commercial Franchise segment includes the sale of Hexvix/Cysview in the U.S. and Europe and other sales from partners and other products. The Development Portfolio segment focuses on the development of pipeline products. The company was founded in 1997 and is headquartered in Oslo, Norway.

KLOX Technologies, Inc. designs and develops therapeutic and cosmetic products. The firm offers fluorescence biomodulation technology. The company was founded by Francesco Bellini in 2007 and is headquartered in Laval, Canada.

Foshan Guangchuangyuan Electronics Co., Ltd., established on 2012-05-07, Business scope includes general items:Sales of power electronic components;software development;Intelligent control system integration;Industrial automatic control system device manufacturing;Industrial automatic control system device sales;Mechanical and electrical equipment manufacturing;Sales of electrical machinery and equipment;Manufacturing of electronic measuring instruments;Sales of electronic measuring instruments;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Domestic trade agent.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Production of Class II Medical Devices;Internet Information Service for Medical Devices;Import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Yue Bei People's Hospital, a subsidiary of Shantou University, is a Chinese company located in Shaoguan that provides medical services.

Suzhou Minxing Medical Information Technology Co., Ltd., established on 2011-03-25, Business scope includes medical software development;Simulation system,Robotic System Design,to develop,Sales,lease,After-sales service;Information system integration service;Internet of Things Technology Services;medical teaching aids,Medical Device Sales;Sales of computer software and provision of technology development,Technical Services,technical consulting.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Central Manchester University Hospital NHS Foundation Trust, established in 2009, ran eight hospitals in Manchester and Trafford: Manchester Royal Infirmary, Royal Manchester Children's Hospital, Saint Mary's Hospital, Manchester, Manchester Royal Eye Hospital and University Dental Hospital of Manchester in Manchester, and Trafford General Hospital, Altrincham Hospital and Stretford Memorial Hospital in Trafford.

Concentric Analgesics, Inc. develops novel, non-opioid therapeutics for the management of acute postsurgical and chronic osteoarthritis pain. The company was founded by John F. Donovan, Frank J. Bellizzi and Craig O. Husfeld in 2014 and is headquartered in San Francisco, CA.

Hui'an Polar Star Technology Co., Ltd., established on 2020-07-29, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Computer System Services;Computer and Office Equipment Repair;software sales;electronics sales;Network Equipment Sales;software development;office services;Graphic design and production;Industrial Design Services;New material technology promotion service(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)